Search Job Title Only
News By Subject
News by Disease
News By Date
Get Our FREE
6/27/2007 10:00:35 AM
June 26 (Reuters) - Canada's EndoCeutics Inc. on Tuesday filed with U.S. regulators to withdraw its planned initial public offering, citing current market conditions among other reasons.
Trends in Life Science Exits: How to Get Best Bang for Your Buck
Raises Euro 15 Million to Advance Oncology Pipeline
Raises SEK 27,7 Million to Fund Clinical Phase III Trial
(PKI) Establishes Wholly Owned Subsidiary in India
Announces CHF 32 Million Series A Funding
MAP Pharmaceuticals, Inc.
Files Registration Statement for Proposed Initial Public Offering
ISTA Pharmaceuticals, Inc.
(ISTA) to Raise $36.75 Million through Private Financing
China Sets Lofty Goals for its Bioindustry
Completes $10 Million Series A Financing to Fund Discovery and Development of Next-Generation Antibiotics
Announces Definitive Agreement for $25.0 Million Private Placement
comments powered by Disqus.
comments powered by
Biotech/Pharma - IPO
Biotech/Pharma - Investor